Novartis to Invest $35M in Gamida Cell

News   Aug 21, 2014

 
Novartis to Invest $35M in Gamida Cell
 
 
 

RELATED ARTICLES

Novel Green Chemistry Method Improves Pharmaceutical Manufacturing Efficiency

News

About 70 percent of pharmaceuticals are manufactured using palladium-driven catalytic processes that are either fast or efficient - but not both. Researchers have now developed a green chemistry method that combines aspects of both processes to improve efficiency at a minimal cost of processing time.

READ MORE

From Human Biopsy to Complex Gut Physiology on a Chip

News

Organ Chip technology using donor-derived human intestinal cells offers advantages over organoids and creates new opportunities for personalized medicine.

READ MORE

Scientists Create Most Sophisticated Human Liver Model Yet

News

The mini-livers can potentially help scientists better understand certain congenital liver diseases as well as speed up efforts to create liver tissue in the lab for transplantation into patients.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE